One of the firststudies to analyze PPARγ status in an in vivo cancer setting examined 55 unrelated sporadic coloncancer samples and revealed 4 PPARγ mutations[28].Moreover, these mutations produced an inactive PPARγ protein. The gene discussed is PPARG; the disease is cancer.